Elevated soluble interleukin-2 receptor levels (sIL-2R), a measure of
T cell activation, have been used as a serum marker for early rejectio
n in solid organ transplant patients. In this preliminary study, we me
asured sequential sIL-2R levels of 53 otherwise immunologically normal
corneal transplant recipients. Eleven of these transplants rejected;
sIL-2R was significantly elevated during the acute rejection episode,
compared to pre-rejection and post-rejection levels (p = 0.01). Five p
atients' sIL-2R rose one to nine months prior to rejection. These data
indicate that sIL-2R levels may correlate with corneal graft rejectio
n and may be predictive of impending rejection. A larger prospective s
tudy with many immunologically normal patients and careful monitoring
of sIL-2R levels prior to and during the acute rejection episode will
be necessary to determine the value of sIL-2R monitoring as a predicti
ve tool for corneal graft rejection.